Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES

🇮🇷Iran

Country: 🇮🇷Iran

Ownership: Private

Established: 1961-01-01

Employees: -

Market Cap: -

Website: http://www.sbmu.ac.ir/

Clinical Trials

The Efficacy and Safety of Topical Vitamin D Drop on Meibomian Gland Function in Patients With Meibomian Gland Dysfunction

Phase 2

Conditions: Meibomian Gland Dysfunction

Interventions: Drug: Topical placebo eye drop
Drug: Topical Vitamin D eye drop

First Posted Date: 2022-08-10

Last Posted Date: 2022-08-10

Lead Sponsor: Shahid Beheshti University of Medical Sciences

Target Recruit Count: 56

Registration Number: NCT05495958

Locations: 🇮🇷
Ophthalmic Research center, Tehran, Iran, Islamic Republic of

The Effect of Erythropoietin in the Treatment of Scleral Necrosis

Phase 2

Conditions: Conjunctival and Scleral Avascular Lesions

Interventions: Drug: Erythropoietin prescription
Drug: Prescription of placebo

First Posted Date: 2022-07-27

Last Posted Date: 2022-07-27

Lead Sponsor: Shahid Beheshti University of Medical Sciences

Target Recruit Count: 60

Registration Number: NCT05476042

Locations: 🇮🇷
Ophthalmic Research center, Tehran, Iran, Islamic Republic of

Home Vision Therapy and Prism Prescription in Presbyopic Persons With Convergence Insufficiency

Not Applicable

Recruiting

Conditions: Convergence Insufficiency

First Posted Date: 2022-04-05

Last Posted Date: 2023-04-25

Lead Sponsor: Shahid Beheshti University of Medical Sciences

Target Recruit Count: 250

Registration Number: NCT05311917

Locations: 🇮🇷
Shahid Beheshti University of Medical Sciences, Tehran, Iran, Islamic Republic of

Comparison of Combined Intravitreal Bevacizumab and Oral Acetazolamide Versus Intravitreal Bevacizumab Alone for the Treatment of Macular Edema Secondary to Retinal Vein Occlusions

Phase 2

Conditions: Macular Edema

Interventions: Drug: intravitreal injection of bevacizumab
Drug: intravitreal injection of bevacizumab with acetazolamide tablets

First Posted Date: 2022-03-22

Last Posted Date: 2022-03-22

Lead Sponsor: Shahid Beheshti University of Medical Sciences

Target Recruit Count: 57

Registration Number: NCT05290948

Locations: 🇮🇷
Ophthalmic Research center, Tehran, Iran, Islamic Republic of

Short Daily Versus Conventional Hemodialysis for COVID-19 Patients

Not Applicable

Completed

Conditions: COVID-19

First Posted Date: 2022-01-28

Last Posted Date: 2022-01-28

Lead Sponsor: Shahid Beheshti University of Medical Sciences

Target Recruit Count: 47

Registration Number: NCT05212675

Locations: 🇮🇷
Nooshin Dalili, Tehran, Iran, Islamic Republic of

Bisoprolol Administration to Prevent Anthracycline-induced Cardiotoxicity

Phase 3

Completed

Conditions: Cardiomyopathies
Systolic Dysfunction
Chemotherapy Effect
Diastolic Dysfunction

Interventions: Drug: Placebo
Drug: Bisoprolol

First Posted Date: 2022-01-03

Last Posted Date: 2022-01-03

Lead Sponsor: Shahid Beheshti University of Medical Sciences

Target Recruit Count: 80

Registration Number: NCT05175066

Locations: 🇮🇷
Rasool Akram hospital, Tehran, Iran, Islamic Republic of

Effects of Ondansetron, Metoclopramide and Granisetron on Perioperative Nausea and Vomiting in Patients Undergone Bariatric Surgery

Phase 3

Completed

Conditions: Vomiting, Postoperative
Perioperative Complication
Nausea
Bariatric Surgery Candidate
Drug Effect

Interventions: Drug: Metoclopramide and Ondanteron
Drug: Granisetron
Drug: Metoclopramide
Drug: Ondansetron

First Posted Date: 2021-10-21

Last Posted Date: 2021-10-29

Lead Sponsor: Shahid Beheshti University of Medical Sciences

Target Recruit Count: 130

Registration Number: NCT05087615

Locations: 🇮🇷
Loghman Hakim Hospital, Tehran, Iran, Islamic Republic of

Combined Intravitreal Bevacizumab With Topical Timolol-Dorzolamide Eye Drops in Diabetic Macular Edema

Phase 2

Conditions: Diabetic Macular Edema

Interventions: Drug: Injections of 1.25 mg of intravitreal bevacizumab with artificial tears
Drug: Injections of 1.25 mg of intravitreal bevacizumab with Timolol and Dorzolamide

First Posted Date: 2021-10-19

Last Posted Date: 2021-10-19

Lead Sponsor: Shahid Beheshti University of Medical Sciences

Target Recruit Count: 62

Registration Number: NCT05083689

Locations: 🇮🇷
Ophthalmic Research Center, Tehran, Iran, Islamic Republic of

Possible Effects of Supplement Therapy With Oral Phenolics on Cluster of Differentiation 163 (CD-163) Biomarker of Patients With Age-related Macular Degeneration

Phase 1

Conditions: Age Related Macular Degeneration

Interventions: Drug: Placebo
Drug: Oral intake of medication

First Posted Date: 2021-08-16

Last Posted Date: 2021-08-16

Lead Sponsor: Shahid Beheshti University of Medical Sciences

Target Recruit Count: 80

Registration Number: NCT05005884

Locations: 🇮🇷
Ophthalmic Research Center, Tehran, Iran, Islamic Republic of

Assessment of the Validity, Reliability, and Feasibility of Two Smartphone Applications for Testing the Visual Acuity

Not Applicable

Completed

Conditions: Blindness
Vision Impairment

First Posted Date: 2021-06-23

Last Posted Date: 2022-07-27

Lead Sponsor: Shahid Beheshti University of Medical Sciences

Target Recruit Count: 120

Registration Number: NCT04936100

Locations: 🇮🇷
Ophthalmic Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran, Islamic Republic of

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy